Jean-Pierre Crinelli
Founder at NOVACYT
Net worth: 30 194 $ as of 2024-04-29
Jean-Pierre Crinelli active positions
Companies | Position | Start | End |
---|---|---|---|
NOVACYT | Director/Board Member | 2006-07-02 | - |
Founder | 2006-07-02 | - | |
Independent Dir/Board Member | 2006-07-02 | - | |
SCI Padapi | Corporate Officer/Principal | - | - |
Alain Fresard Technologies-Micromecanique | Corporate Officer/Principal | - | - |
Novacyt UK Holdings Ltd.
Novacyt UK Holdings Ltd. BiotechnologyHealth Technology Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy. | Director/Board Member | - | - |
Career history of Jean-Pierre Crinelli
Former positions of Jean-Pierre Crinelli
Companies | Position | Start | End |
---|---|---|---|
CUP 92 SAS
CUP 92 SAS Medical SpecialtiesHealth Technology CUP 92 SAS operates as a holding company with interest in the provision of solutions in cytology and molecular biology fields. The company was founded on March 11, 2010 and is headquartered in Compiegne, France. | Chairman | - | - |
Statistics
International
France | 5 |
United Kingdom | 2 |
Operational
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Founder | 1 |
Sectoral
Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
NOVACYT | Health Technology |
Private companies | 4 |
---|---|
CUP 92 SAS
CUP 92 SAS Medical SpecialtiesHealth Technology CUP 92 SAS operates as a holding company with interest in the provision of solutions in cytology and molecular biology fields. The company was founded on March 11, 2010 and is headquartered in Compiegne, France. | Health Technology |
SCI Padapi | |
Alain Fresard Technologies-Micromecanique | |
Novacyt UK Holdings Ltd.
Novacyt UK Holdings Ltd. BiotechnologyHealth Technology Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy. | Health Technology |
- Stock Market
- Insiders
- Jean-Pierre Crinelli
- Experience